First test of dual vaccine targets two common respiratory viruses
⭐️ VACCINE ⭐️
Ongoing
This is an early-stage study to test the safety and immune response of a new vaccine candidate, VXB-241. The goal is to see if it can help prevent serious lung infections caused by two common viruses: Respiratory Syncytial Virus (RSV) and human metapneumovirus (HMPV). The study w…
Phase: PHASE1 • Sponsor: Vicebio Australia Proprietary Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:32 UTC